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S U M M A R Y
Objectives: To identify the clinical characteristics of outpatients with ﬂu-like illnesses stratiﬁed by
inﬂuenza A H1N1 status.
Methods: The study was conducted at the H1N1 staff clinic of Sultan Qaboos University Hospital in
Muscat, Oman. The population consisted of university students and university/hospital staff and their
family members. All adult patients who presented to the H1N1 clinic with an inﬂuenza-like illness over a
4-month period (from August until the end of November 2009) were included. Real-time reverse
transcriptase (rRT) PCR was used for the diagnosis of H1N1 inﬂuenza. Demographic data, clinical signs
and symptoms, history of exposure to H1N1, history of recent travel, and co-morbid conditions were
documented. Analyses were conducted using univariate and multivariate statistical techniques.
Results: Out of the 2318 patients identiﬁed, 27% (n = 616) were positive for H1N1 inﬂuenza. The mean
temperature in the H1N1-positive group was signiﬁcantly higher than in the negative group (38.3 8C vs.
37.2 8C; p < 0.001). Proportions of patients who reported cough, sore throat, headache, myalgia,
gastrointestinal symptoms, exposure to a conﬁrmed case of H1N1, and a history of travel were
signiﬁcantly higher in the H1N1-positive group as compared to the swab-negative group. However, the
multivariable logistic model identiﬁed only the following signiﬁcant predictor variables of H1N1
infection: younger age, fever (37.8 8C), sore throat, myalgia, diarrhea, and exposure to a conﬁrmed
H1N1 case within the last 7 days.
Conclusions: This study provides useful data on the clinical characteristics of H1N1 inﬂuenza in a large
outpatient population from the Middle East. Patients who tested positive for H1N1 were more likely to
have fever, sore throat, diarrhea, and myalgia compared to those with other inﬂuenza-like illnesses.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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In late March 2009, an outbreak of inﬂuenza A H1N1 virus
infection was detected in Mexico. The virus then spread rapidly to
many other regions of the world.1,2 In late April, the World Health
Organization (WHO) announced the emergence of a novel
inﬂuenza A virus, and in June 2009, the WHO raised its pandemic
alert level to the highest level.3 More than 214 countries, including
the countries and territories of the Middle East, reported
laboratory-conﬁrmed cases of pandemic H1N1 inﬂuenza A.4 The
pandemic was declared to be over in August 2010.5 The ﬁrst
conﬁrmed case of H1N1 in Oman was reported in June 2009, and* Corresponding author. Tel.: +968 99 834077; fax: +968 24 413419.
E-mail address: abdulaziz@squ.edu.om (A. Al-Mahrezi).
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http://dx.doi.org/10.1016/j.ijid.2012.02.015the total number of conﬁrmed cases detected by the beginning of
January 2010 was 7040 with 31 deaths.6 As of November 2009, the
total number of conﬁrmed cases in the Eastern Mediterranean
region (to which Oman belongs) was 22 689, and 137 of these cases
had died.7
The spectrum of H1N1 inﬂuenza has been described to range
from a non-febrile, mild upper respiratory tract illness to severe
or fatal pneumonia.8 The most commonly reported symptoms
are cough, fever, sore throat, malaise, and headache.8–10 The
least commonly reported symptoms are nausea, vomiting and/or
diarrhea.8–10 The clinical diagnosis of an inﬂuenza infection is
often elusive given its non-speciﬁc presentation. From a health
perspective, differentiating between inﬂuenza and inﬂuenza-
like illnesses (ILI) caused by other respiratory pathogens could
be very valuable because of the availability of speciﬁc antiviral
therapies,11 the potential serious complications of this disease,ses. Published by Elsevier Ltd. All rights reserved.
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pandemics.
There are currently several published studies12–14 that have
compared the clinical characteristics of patients affected by
seasonal inﬂuenza and those presenting with ILI caused by other
respiratory pathogens. As there are differences in socio-demo-
graphic and epidemiological trends between different countries,
clinical characteristics and disease severity may differ among
different populations. Therefore, we aimed to identify the
differences in clinical characteristics between patients with an
ILI who are negative for H1N1 and those who are positive for H1N1
in an outpatient Omani population.
2. Methods
We conducted a retrospective electronic chart review of all
adult patients (17 years) who attended the H1N1 staff clinic at
the health center of Sultan Qaboos University Hospital (SQUH).
This is a government hospital located in the capital city of Muscat,
Oman. We reviewed the charts of patients who were registered
from August 1, 2009 to November 30, 2009, which was the time of
the H1N1 epidemic in Oman. The H1N1 staff clinic is run by
medical ofﬁcers, family physicians, and family medicine residents.
The study population consisted of university students and
university/hospital staff and their family members. These included
both Omanis and expatriates from all over the world. The
university health center at SQUH is not open to the public; all
non-eligible patients are routinely directed to the emergency
department of the hospital.
All patients, with self-reported inﬂuenza-like symptoms
including fever, cough, sore throat, headache, nasal symptoms,
and myalgia, with or without documented fever, attended the
H1N1 clinic. All patients with such symptoms were tested for
H1N1. Two swabs were taken for each patient, one from
nasopharynx and the other from the throat. Both swabs were
collected in the same transport medium. An oropharyngeal swab
was considered as an alternative to the nasopharyngeal swab in the
case that the clinician failed to reach the nasopharynx. Real-time
reverse transcriptase (rRT) PCR was used for the diagnosis of H1N1
inﬂuenza virus infection. The advantages of using this test include
its ability to yield relatively rapid results and to differentiate
between inﬂuenza types and subtypes.15 The laboratory reported
either positivity or negativity for H1N1. Other respiratory
pathogens were not reported.
A data collection form was developed to include the following
variables: age, gender, nationality (Omani vs. non-Omani),
temperature in degrees Celsius, time from symptom onset to
presentation in days, the presence of symptoms (sore throat,
cough, nasal symptoms, headache, myalgia, nausea, vomiting, and
diarrhea), the presence of co-morbid conditions (asthma, chronic
obstructive pulmonary disease, interstitial lung disease, cardio-
vascular disease, diabetes, pregnancy, HIV, malignancy, and use of
immunosuppressant drugs), a history of exposure to H1N1 within
the last 7 days, a history of travel within the last 7 days, whether
hospital admission was required or not, and the swab status.
This study was not funded. Ethical approval for the study was
obtained from the Ethical Review Committee (ERC) of the College
of Medicine and Health Sciences, Sultan Qaboos University.
2.1. Statistical analysis
Descriptive statistics were used to describe the data. For
categorical variables, frequencies and percentages were reported.
Differences between groups (H1N1 status, negative/positive) were
analyzed using Pearson’s Chi-square tests (or Fisher’s exact tests
for cells less than 5). For the variable temperature, the mean andstandard deviation were used to present the data, while analysis
was performed using the Student’s t-test. For variables that were
not normally distributed, medians and interquartile ranges (IQR)
were used to describe the data, while the analyses were conducted
using the Mann–Whitney test.
The associations between H1N1 and the various predictive
demographic and clinical symptoms were assessed using multi-
variable logistic regression. The dependent outcome variable was
H1N1 inﬂuenza, while the predictor variables were age, gender,
nationality (Omani/non-Omani), fever (temperature 37.8 8C),
sore throat, cough, headache, myalgia, vomiting, diarrhea, rhinor-
rhea, exposure to a conﬁrmed H1N1 case within the last 7 days, and
history of travel. The goodness-of-ﬁt of the logistic model was
examined using the Hosmer–Lemeshow goodness-of-ﬁt statistic.16
An a priori two-tailed level of signiﬁcance was set at the 0.05 level.
Statistical analyses were conducted using STATA version 12.0
(STATA Corp., College Station, TX, USA).
3. Results
In total, the electronic medical records of 2355 patients were
reviewed. Patients with missing or incomplete information, or for
whom an H1N1 swab could not be performed, were excluded from
the study. There were 26 incomplete records, 11 in the H1N1-
positive group and 15 in the swab-negative group; in an additional
11 cases, either a swab could not be taken or it was inadequate.
The comparison of demographic information, clinical signs and
symptoms, underlying co-morbid conditions, exposure history,
and travel history of the study participants from both groups are
presented in Table 1. Out of 2318 patients, 1702 (73%) were
negative for H1N1 inﬂuenza and 616 (27%) were positive for H1N1.
The overall median age was 25 (IQR 21–34) years. The majority of
the patients were Omanis (81%; n = 1870). Among the study
participants, males constituted 53% of the swab-negative group
and 57% of the H1N1-positive group. Approximately 28% of
patients in the swab-negative group and 25% of patients in the
H1N1-positive group were health care professionals. None of our
patients required referral for hospitalization.
The mean temperature in the H1N1-positive group was
signiﬁcantly higher than that in the swab-negative group
(38.3 8C vs. 37.2 8C; p < 0.001). Moreover, 78% of the patients in
the H1N1-positive group had a temperature 37.8 8C compared to
16% in the swab-negative group (p < 0.001). The proportions of
patients who reported cough, sore throat, headache, myalgia,
gastrointestinal symptoms, exposure to a conﬁrmed case of H1N1,
and a history of travel were signiﬁcantly higher in the H1N1-
positive group as compared to the swab-negative group. No
signiﬁcant differences were found between the two groups with
regard to the occurrence of co-morbid conditions or the time from
symptom onset to presentation.
Utilizing the stepwise-backward elimination method, the
multivariable logistic model (Table 2) demonstrated that signiﬁ-
cant variables included younger age, exposure to a conﬁrmed
H1N1 case, temperature 37.8 8C, sore throat, diarrhea, and
myalgia.
4. Discussion
This observational study describes an outpatient population of
2318 symptomatic adults who visited H1N1 clinics during the
2009 H1N1 pandemic in Oman between August 1 and November
30, 2009. Almost a third (27%) of patients were found to be positive
for H1N1. According to our ﬁndings, these patients were much
more likely to report the following symptoms: fever, cough, sore
throat, headache, myalgia, vomiting, and diarrhea. Furthermore,
swab-positive patients had a signiﬁcantly higher mean tempera-
Table 1
Demographic and clinical characteristics of the study cohort stratiﬁed by H1N1 status (N = 2318)a
Characteristic All H1N1 status p-Value
Negative
(n = 1702; 73%)
Positive
(n = 616; 27%)
Demographic characteristics
Age, years, median (IQR) 25 (21–34) 25 (21–34) 25 (21–33) 0.345
Male gender 1251 (54.0%) 900 (52.9%) 351 (57.0%) 0.080
Omani 1870 (80.7%) 1354 (79.6%) 516 (83.8%) 0.023
Exposureb 762 (32.9%) 487 (28.6%) 275 (44.6%) <0.001
Travel 55 (2.4%) 31 (1.8%) 24 (3.9%) 0.004
Health care provider 633 (27.3%) 478 (28.1%) 155 (25.2%) 0.163
Clinical characteristics
Temperature, 8C, mean ( SD) 37.5 ( 0.8) 37.2 ( 0.6) 38.3 ( 0.8) <0.001
Temperature 37.8 8C 743 (32.1%) 265 (15.6%) 478 (77.6%) <0.001
Duration of symptoms, days, median (IQR) 2 (1–2) 2 (1–2) 2 (1–2) 0.939
Sore throat 1365 (58.9%) 864 (50.8%) 501 (81.3%) <0.001
Cough 1702 (73.4%) 1200 (70.5%) 502 (81.5%) <0.001
Nasal symptoms 1703 (73.5%) 1286 (75.6%) 417 (67.7%) <0.001
Headache 460 (19.8%) 285 (16.7%) 175 (28.4%) <0.001
Myalgia 612 (26.4%) 316 (18.6%) 296 (48.1%) <0.001
Vomiting 120 (5.2%) 62 (3.6%) 58 (9.4%) <0.001
Diarrhea 191 (8.2%) 79 (4.6%) 112 (18.2%) <0.001
Co-morbidity
Asthma 109 (4.7%) 86 (5.1%) 23 (3.7%) 0.185
Diabetes 44 (1.9%) 37 (2.2%) 7 (1.1%) 0.106
Pregnancy 53 (2.3%) 43 (2.5%) 10 (1.6%) 0.199
COPD 7 (0.3%) 5 (0.3%) 2 (0.3%) 1.000
IQR, interquartile range; SD, standard deviation; COPD, chronic obstructive pulmonary disease.
a Results are n (%), unless otherwise stated. Analyses were conducted using the Student’s t-test, Mann–Whitney test, Pearson’s Chi-square test, or Fisher’s exact test,
whenever appropriate.
b Exposure to a conﬁrmed H1N1 case within the last 7 days.
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suspected case of H1N1 and more likely to have a history of recent
travel.
Fever and cough have been reported to be the two best
predictive symptoms for inﬂuenza infection, particularly in elderly
individuals.12,17 These two key symptoms have also been
described as the most common amongst H1N1-infected
patients.9,10,18,19 Another commonly reported symptom is sore
throat.9,20
According to our results, 18% of H1N1 patients complained of
diarrhea and 9% reported vomiting. These were the least
commonly reported symptoms by our patients. The frequenciesTable 2
Predictive symptoms of H1N1 in the study cohort using multivariable logistic
regression (N = 2318)a
Predictor AOR 95% CI p-Value
Male 1.19 0.93–1.53 0. 158
Age 0.96 0.95–0.98 <0.001
Omani citizen 1.25 0.85–1.83 0.252
Temperature 37.8 8C 14.5 11.1–18.7 <0.001
Sore throat 1.90 1.44–2.52 <0.001
Cough 1.10 0.80–1.50 0.554
Headache 0.76 0.56–1.03 0.072
Myalgia 2.05 1.56–2.69 <0.001
Vomiting 1.49 0.86–2.58 0.158
Diarrhea 3.46 2.29–5.23 <0.001
Nasal symptoms 1.21 0.93–1.59 0.160
Exposure to a conﬁrmed
H1N1 case within
the last 7 days
1.71 1.33–2.20 <0.001
Travel 1.69 0.82–3.50 0.156
AOR, adjusted odds ratio; CI, conﬁdence interval.
a The ﬁnal logistic model is statistically signiﬁcant (likelihood ratio Chi-square
(13) = 937.98; p < 0.001). The Hosmer–Lemeshow Chi-square statistic (a measure of
the goodness-of-ﬁt) was 5.72 and the p-value was 0.679. The model also had a C-
index of 0.87 denoting good discriminatory ability. The pseudo R2 was 35%. The
model correctly classiﬁed 84% of the H1N1 cases.of both these symptoms were lower than those reported by
Dawood et al. (25% for each symptom),9 but higher than those
reported in other studies.21,22 In a comparison between patients
infected with pandemic H1N1 (2009) inﬂuenza and those infected
with seasonal inﬂuenza, Carcione et al. identiﬁed diarrhea as a
signiﬁcant variable distinguishing H1N1-infected patients.13
However, a study from Singapore did not conﬁrm the same
ﬁnding.23
Our multivariate analyses identiﬁed the following signiﬁcant
variables: younger age, exposure to a conﬁrmed case, temperature
37.8 8C, sore throat, diarrhea, and myalgia. The ﬁnding that H1N1
virus affects predominantly younger individuals has been reported
by most of the previous studies.9,20,21 The most likely reason for
this ﬁnding is the cross-reactive immunity in older patients (age
>60 years), which has arisen from their longer lifetime exposure to
strains similar to that of the pandemic H1N1 virus.24 Ong et al.
reported that fever is a signiﬁcant predictor of a laboratory
diagnosis of H1N1.12 In another study, age <65 years and cough
were found to be independent predictors of pandemic H1N1
(2009) virus.25 Results from studies testing various clinical models
and case deﬁnitions that aim to identify patients with inﬂuenza
based solely on clinical characteristics have been disappointing.26–
28 Studies have generally shown that ruling out inﬂuenza using
clinical and contextual information is easier than ruling it in.28,29 It
has been suggested that other contextual information, such as the
knowledge of an epidemic, is needed in order to improve the
sensitivity of a clinical case deﬁnition.28
Our study has several limitations. The study population was not
representative of a typical outpatient setting, since it consisted of
only young and relatively healthy individuals and excluded
children, elderly individuals, and patients with major co-morbid
conditions. H1N1 cases may have been missed if the swab was not
taken properly or obtained late in the course of the disease. It is not
clear what respiratory pathogens were involved in our H1N1-
negative group since no other respiratory pathogens except H1N1
were reported. As our patients were only seen in the outpatient
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settings.
In summary, our study provides useful data on the clinical
characteristics of the pandemic H1N1 (2009) virus in a large
outpatient population from the Middle East. Our ﬁndings indicate
that the clinical presentation of H1N1 infection can, to some
extent, be distinguishable from that of an ILI caused by other
pathogens, by the presence of the following predictor variables:
younger age, high-grade fever, sore throat, myalgia, diarrhea, and a
positive exposure history.
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